KORLYM Trademark

Trademark Overview

On Thursday, June 24, 2021, a trademark application was filed for KORLYM with the United States Patent and Trademark Office. The USPTO has given the KORLYM trademark a serial number of 90792899. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, September 26, 2024. This trademark is owned by CORCEPT THERAPEUTICS INCORPORATED. The KORLYM trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of cardiovascular and gastroenterlogic diseases and disorders
korlym

General Information

Serial Number90792899
Word MarkKORLYM
Filing DateThursday, June 24, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, September 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 18, 2022

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of cardiovascular and gastroenterlogic diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 8, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCORCEPT THERAPEUTICS INCORPORATED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMENLO PARK, CA 94025
Party NameCORCEPT THERAPEUTICS INCORPORATED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMENLO PARK, CA 94025

Trademark Events

Event DateEvent Description
Monday, June 28, 2021NEW APPLICATION ENTERED
Wednesday, September 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 16, 2022ASSIGNED TO EXAMINER
Wednesday, March 16, 2022NON-FINAL ACTION WRITTEN
Wednesday, March 16, 2022NON-FINAL ACTION E-MAILED
Wednesday, March 16, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 12, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 13, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 18, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 18, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, November 21, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 21, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 21, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 24, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 24, 2023SOU EXTENSION 1 FILED
Friday, March 24, 2023SOU EXTENSION 1 GRANTED
Tuesday, March 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 30, 2023SOU EXTENSION 2 FILED
Thursday, November 30, 2023SOU EXTENSION 2 GRANTED
Friday, December 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 26, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 26, 2024SOU EXTENSION 4 FILED
Thursday, September 26, 2024SOU EXTENSION 4 GRANTED
Wednesday, March 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 30, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 5, 2024SOU EXTENSION 3 GRANTED
Tuesday, March 5, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 5, 2024SOU EXTENSION 3 FILED

Related Keywords

korlym diseases disorders gastroenterlogic cardiovascular preparations treatment pharmaceutical